Apoptotic mechanisms in neurodegeneration: Possible relevance to glaucoma

European Journal of Ophthalmology

Volumn 9, Issue SUPPL. 1, 1999, Pages

  Tatton, W G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; BAX; BCL 2; BCL x(L); Deprenyl; Neuroprotection

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; PROTEIN BCL 2; PROTEIN BCL X; SELEGILINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CELL ULTRASTRUCTURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG EFFECT; GENETIC TRANSCRIPTION; GLAUCOMA; MEMBRANE POTENTIAL; MEMBRANE RUPTURE; MITOCHONDRIAL MEMBRANE; NERVE DEGENERATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0032904243     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219900901s10     Document Type: Review

References (52)

1. Kerr JFR. Shrinkage necrosis: a distinct form of cell death. J Pathol 1971; 105: 13-20.
2. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997; 18: 44-51.
3. Mazarakis ND, Edwards AD, Mehmet H. Apoptosis in neural development and disease. Arch Dis Child Fetal Neonatal Ed 1997; 77: F165-70.
4. Lipton SA, Nicotera P. Calcium, free radicals and excitotoxins in neuronal apoptosis. Cell Calcium 1998; 23: 165-71.
5. Tatton NA, Kish SJ. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neurosci 1997; 77: 1037-48.
6. Guo Q, Sopher BL, Furukawa K, et al. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid betapeptide: involvement of calcium and oxyradicals. J Neurosci 1997; 17: 4212-22.
7. Wadia JS, Chalmers-Redmari RME, Ju WJH, Carlile GW, Phillips JL, Tatton WG. Mitochondrial membrane potential and nuclear changes in apoptosis caused by trophic withdrawal: Time course and modification by (-)-deprenyl. J Neurosci 1998; 18: 932-47.
8. Chalmers-RedmanRM, Fraser AD, Ju WY, Wadia J, Tatton NA, Tatton WG. Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischaemia. Int Rev Neurobiol 1997; 40: 1-25.
9. Tatton WG, Chalmers-Redman RM, Ju WY, Wadia J, Tatton NA. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J Neural Transm Suppl 1997; 49: 245-68.
10. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary openangle glaucoma. Arch Ophthalmol 1997; 115: 1031-5.
11. Okisaka S, Murakami A, Mizukawa A, Ito J. Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes. Jpn J Ophthalmol 1997; 41: 84-8.
12. Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol 1995; 23: 85-91.
13. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36: 774-86.
14. Wax MB, Tezel G, Edward PD. Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma (see comments). Arch Ophthalmol 1998; 116: 993-1001.
15. Savitz SI, Rosenbaum DM. Apoptosis in neurological disease. Neurosurg 1998; 42: 555-72 (discussion 573-574).
16. Anglade P, Vyas S, Hirsch EC, Agid Y. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Histopathol 1997; 12: 603-10.
17. Tatton NA, Maclean-Fraser A, Tatton WG, Perl DP, Olanow CW. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann Neurol 1998; 44 (suppl): S142-8.
18. Group TPS. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1993; 328: 176-83.
19. Ward CD. Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study. J Neurol Neurosurg Psychiatry 1994; 57: 217-20.
20. Tatton WG, Chalmers-Redman RM. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. Neurol Clin 1996; 47: S171-83.
21. Kragten E, Lalande I, Zimmermann K, et al. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J Biol Chem 1998; 273: 5821-8.
22. Le W, Jankovic J, Xie W, Kong R, Appel SH. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition. Neurosci Lett 1997; 224: 197-200.
23. Maruyama W, Takahashi T, Naoi M. (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide. J Neurochem 1998; 70: 2510-5.
24. Paterson IA, Barber AJ, Gelowitz DL, Voll C. (-)Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells. Neurosci Biobehav Rev 1997; 21: 181-6.
25. Paterson IA, Zhang D, Warrington RC, Boulton AA. R-deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium. J Neurochem 1998; 70: 515-23.
26. Ragaiey T, Ma JX, Jiang WJ, Greene W, Seigel GM, Stewart WC. L-deprenyl protects injured retinal precursor cells in vitro. J Ocul Pharmacol Ther 1997; 13: 479-88.
27. Tatton WG, Ju WY, Holland DP, Tai C, Kwan M. (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem 1994; 63: 1572-5.
28. Tatton WG, Chalmers-Redman RM. Mitochondria in neurodegenerative apoptosis: an opportunity for therapy? Ann Neurol 1998; 44 (suppl): S134-41.
29. Tatton WG, Olanow CW. Apoptosis in neurodegenerative diseases: Role of mitochondria. Biochim Biophys Acta 1999 (in press).
30. Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1998; 1366: 151-65.
31. Zamzami N, Brenner C, Marzo I, Susin SA, Kroemer G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 1998; 16: 2265-82.
32. Marzo I, Brenner C, Zamzami N, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998; 281: 2027-31.
33. Ishitani R, Kimura M, Sunaga K, Katsube N, Tanaka M, Chuang DM. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmacol Exp Ther 1996a; 278: 447-54.
34. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang DM. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem 1996b; 66: 928-35.
35. +-induced apoptosis but not necrosis of cultured cerebellar granule cells. Mol Pharmacol 1997; 51: 542-50.
36. Sunaga K, Takahashi H, Chuang DM, Ishitani R. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci Lett 1995; 200: 133-6.
37. Nagy E, Rigby WFC. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J Biol Chem 1995; 270: 2755-63.
38. Carlile GW, Tatton WG, Borden KL. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase. Biochem J 1998; 335: 691-6.
39. Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang DM. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 1998; 53: 701-7.
40. Saunders PA, Chalecka-Franaszek E, Chuang DM. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem 1997; 69: 1820-8.
41. Sawa A, Khan AA, Hester LD, Snyder SH. Glyceraldehyde-3-phosphate dehydrogenase: Nuclear translocation participates in neuronal and nonneuronal cell death. Proc Nat Acad Sci (USA) 1997; 94: 11669-74.
42. Shashidharan P, Chalmers-Redman R, Yuen T, et al. Green fluorescence protein reveals nuclear translocation of GAPDH during apoptosis in living cells. Proc Soc Neurosc 1998; 24: 1556.
43. Kim H, Feil IK, Verlinde CL, Petra PH, Hol WG. Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding site. J Biochem 1995; 34: 14975-86.
44. Wright DA, Siciliano MJ, Baptist JN. Genetic evidence for the tetramer structure of glyceraldehyde-3-phosphate dehydrogenase. Experientia 1972; 28: 888-9.
45. Itoga M, Tsuchiya M, Ishino H, Shimoyama M. Nitric oxide-induced modification of glyceraldehyde-3-phosphate dehydrogenase with NAD(+) is not ADP-ribosylation. J Biochem 1997; 121: 1041-6.
46. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol: Cell Physiol 1996; 40: C1424-37.
47. Marin P, Maus M, Bockaert J, Glowinski J, Premont J. Oxygen free radicals enhance the nitric oxide-induced covalent NAD(+)-linkage to neuronal glyceraldehyde-3-phosphate dehydrogenase. Biochem J 1995; 309: 891-8.
48. McDonald LJ, Moss J. Nitric oxide and NAD-dependent protein modification. Mo Cell Biochem 1994; 138: 201-6.
49. Zhang J, Snyder SH. Nitric oxide in the nervous system. Ann Rev Pharmacol Toxicol 1995; 35: 213-33.
50. Morgenegg G, Winkler GC, Hubscher U, Heizmann CW, Mous J, Kuenzle CC. Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J Neurochem 1986; 47: 54-62.
51. Minton AP, Wilf J. Effect of macromolecular crowding upon the structure and function of an enzyme: glyceraldehyde-3-phosphate dehydrogenase. J Biochem 1981; 20: 4821-6.
52. Buys YM, Trope GE, Tatton WG. (-)-Deprenyl increases the survival of rat retinal ganglion cells after optic nerve crush. Curr Eye Res 1995; 14: 119-26.